BioElectronics Corporation Share Price
Equities
BIEL
US09062H1086
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | -.--% | -.--% |
25/03 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
23/02 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
Sales 2020 | 830K 69.25M | Sales 2021 | 1.61M 134M | Capitalization | 25.6M 2.14B |
---|---|---|---|---|---|
Net income 2020 | -1M -83.47M | Net income 2021 | - 0 | EV / Sales 2020 | 53.6 x |
Net Debt 2020 | 13.07M 1.09B | Net Debt 2021 | 13.34M 1.11B | EV / Sales 2021 | 24.2 x |
P/E ratio 2020 |
-26.5
x | P/E ratio 2021 |
-95.5
x | Employees | 9 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
1 day | +100.00% | ||
Current month | -33.33% | ||
3 months | -33.33% | ||
6 months | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Kelly A. Whelan
CEO | Chief Executive Officer | - | 15/19/15 |
Keith E. Nalepka
SAM | Sales & Marketing | - | 01/17/01 |
John M. Martinez
PRN | Corporate Officer/Principal | - | 01/02/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 83 | 15/20/15 | |
Keith E. Nalepka
SAM | Sales & Marketing | - | 01/17/01 |
Kelly A. Whelan
CEO | Chief Executive Officer | - | 15/19/15 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 0.0002 | +100.00% | 2,485,000 |
29/24/29 | 0.0001 | -33.33% | 5,838,871 |
26/24/26 | 0.00015 | -25.00% | 28,245,000 |
25/24/25 | 0.0002 | -.--% | 7,306,938 |
24/24/24 | 0.0002 | +33.33% | 56,127,000 |
Delayed Quote OTC Markets, April 30, 2024 at 09:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-.--% | 4.94M | |
+7.15% | 217B | |
+6.60% | 183B | |
+9.86% | 131B | |
+24.32% | 106B | |
-0.95% | 62.16B | |
+11.04% | 51.02B | |
+4.81% | 50.89B | |
-1.43% | 40.16B | |
+24.40% | 31.44B |
- Stock Market
- Equities
- BIEL Stock